Table of Content

1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Technology Trends
4.4. Regulatory Analysis
4.4.1. Regulations for IVD Products
4.4.1.1. North America
4.4.1.1.1. U.S.
4.4.1.1.2. Canada
4.4.1.2. Europe
4.4.1.3. Asia-Pacific
4.4.1.3.1. China
4.4.1.3.2. Japan
4.4.1.3.3. India
4.4.1.4. Latin America
4.4.1.5. Middle East & Africa
4.4.2. Regulations for Quality Management
4.4.2.1. North America
4.4.2.1.1. U.S.
4.4.2.1.2. Canada
4.4.2.2. Europe
4.4.2.2.1. Germany
4.4.2.2.2. France
4.4.2.2.3. U.K.
4.4.2.2.4. Italy
4.4.2.2.5. Spain
4.4.2.2.6. Rest of Europe (RoE)
4.4.2.3. Asia-Pacific
4.4.2.3.1. China
4.4.2.3.2. Japan
4.4.2.3.3. India
4.4.2.3.4. Rest of Asia-Pacific (RoAPAC)
4.4.2.4. Latin America
4.4.2.5. Middle East & Africa
4.5. Pricing Analysis
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition
4.7. Associated Market Analysis: In Vitro Diagnostics (IVD) Market

5. IVD Quality Control Market Assessment?by Offering
5.1. Overview
5.2. Quality Control Products
5.2.1. Quality Control Products, by Type
5.2.1.1. Serum/Plasma-based Controls
5.2.1.2. Whole Blood-based Controls
5.2.1.3. Urine-based Controls
5.2.1.4. Other Controls
5.2.2. Quality Control Products, by Function
5.2.2.1. Independent Controls
5.2.2.2. Instrument-specific Controls
5.3. Quality Assessment Services
5.4. Data Management Solutions

6. IVD Quality Control Market Assessment?by Technology
6.1. Overview
6.2. Immunoassay/Immunochemistry
6.3. Biochemistry/Clinical Chemistry
6.4. Molecular Diagnostics
6.5. Hematology
6.6. Coagulation/Hemostasis
6.7. Microbiology
6.8. Other Technologies

7. Global IVD Quality Control Market Assessment?by Application
7.1. Overview
7.2. Infectious Diseases
7.3. Oncology
7.4. Cardiology
7.5. Autoimmune Disorders
7.6. Neurology
7.7. Other Applications

8. IVD Quality Control Market Assessment?by End User
8.1. Overview
8.2. Hospitals & Clinics
8.3. Diagnostic Laboratories
8.4. Academic Institutes & Research Laboratories
8.5. Other End Users

9. IVD Quality Control Market Assessment?by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa

10. Competition Analysis
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies

11. Company Profiles
11.1. Siemens Healthineers AG
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. SWOT Analysis
11.2. Bio-Rad Laboratories, Inc.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Strategic Developments
11.2.5. SWOT Analysis
11.3. Danaher Corporation
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.3.4. SWOT Analysis
11.4. LGC Group
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.4.5. SWOT Analysis
11.5. Thermo Fisher Scientific Inc.
11.5.1. Business Overview
11.5.2. Financial Overview
11.5.3. Product Portfolio
11.5.4. Strategic Developments
11.5.5. SWOT Analysis
11.6. Randox Laboratories Ltd.
11.6.1. Company Overview
11.6.2. Product Portfolio
11.6.3. Strategic Developments
11.6.4. SWOT Analysis
11.7. SERO AS
11.7.1. Company Overview
11.7.2. Product Portfolio
11.7.3. Strategic Developments
11.8. QuidelOrtho Corporation
11.8.1. Business Overview
11.8.2. Financial Overview
11.8.3. Product Portfolio
11.8.4. Strategic Developments
11.9. Streck LLC
11.9.1. Company Overview
11.9.2. Product Portfolio
11.9.3. Strategic Developments
11.10. Microbiologics, Inc.
11.10.1. Company Overview
11.10.2. Product Portfolio
11.10.3. Strategic Developments
11.11. Bio-Techne Corporation
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Product Portfolio
11.11.4. Strategic Developments

12. Appendix
12.1. Available Customization
12.2. Related Reports



List of Figures

Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global IVD Quality Control Market, by Offering, 2023 Vs. 2030 (USD Million)
Figure 8 Global IVD Quality Control Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 9 Global IVD Quality Control Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 10 Global IVD Quality Control Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 11 Global IVD Quality Control Market, by Geography
Figure 12 Healthcare Expenditure as a Percentage of GDP in Major Countries, 2015 Vs. 2020
Figure 13 Estimated Number of People Living With HIV, by Region, 2015 Vs. 2021 (In Thousand)
Figure 14 Global Diabetes Prevalence in People Aged 20–79 Years, by Region, 2021 Vs. 2030 Vs. 2045 (In Million)
Figure 15 USFDA Regulatory Pathways for IVD Products
Figure 16 EU Regulatory Pathway - IVDR 2017/746
Figure 17 China: Medical Device Classification and Pre-Market Requirements for IVD Devices
Figure 18 Porter’s Five Forces Analysis
Figure 19 Global In Vitro Diagnostics (IVD) Market, by Offering, 2023 (USD Million)
Figure 20 Global IVD Quality Control Market, by Offering, 2023 Vs. 2030 (USD Million)
Figure 21 Global IVD Quality Control Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 22 Global IVD Quality Control Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 23 Global IVD Quality Control Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 24 Global IVD Quality Control Market Assessment, by Country/Region, 2023–2030 (USD Million)
Figure 25 North America: IVD Quality Control Market Snapshot
Figure 26 Europe: IVD Quality Control Market Snapshot
Figure 27 Health Expenditure (2015–2020)
Figure 28 Asia-Pacific: IVD Quality Control Market Snapshot
Figure 29 China: Independent Medical Laboratories Market, 2015–2019 (USD Million)
Figure 30 Latin America: IVD Quality Control Market Snapshot
Figure 31 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 32 IVD Quality Control Market: Competitive Benchmarking, by Offering
Figure 33 IVD Quality Control Market: Competitive Benchmarking, by Geography
Figure 34 Competitive Dashboard: IVD Quality Control Market
Figure 35 Siemens Healthineers AG: Financial Overview (2022)
Figure 36 Bio-Rad Laboratories, Inc.: Financial Overview (2022)
Figure 37 Danaher Corporation: Financial Overview (2022)
Figure 38 LGC GROUP: Financial Overview (2021)
Figure 39 Thermo Fisher Scientific Inc.: Financial Overview (2022)
Figure 40 QuidelOrtho Corporation: Financial Overview (2022)
Figure 41 Bio-Techne Corporation: Financial Overview (2022)